Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Rituxan and IL-2 in Patients With Low Grade or Follicular B-Cell Lymphoma

NCT00003356 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT00003356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Rituxan and IL-2 in Patients With Low Grade or Follicular B-Cell Lymphoma
Lead sponsor
University of Rochester
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 1997
Completion date
May 31, 2002
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma